Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 8 results found. Search for [ medicine used for hepatitis c ]

Results 1 to 8 of 8
PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research


PTI
May 5, 2020
The results are also supported by the fact that both SARS-CoV-2 and the hepatitis C virus are a virus of the same type, a so-called single-stranded RNA virus, explained Efferth


Aprajita Sharma
New Delhi, October 30, 2019
The New Delhi-based company has created a community of Ayurvedic doctors and is empowering them with better access to knowledge and quality medicines


Joe C Mathew
New Delhi, June 23, 2017
Medicines Sans Frontiers (MSF) has urged India to withstand U.S. pressure to change its drug regulatory and patent system as it could result in millions of people in the U.S. and around the world losing their lifeline of affordable medicines.


By David Singh Grewal and Amy Kapczynski
Delhi, December 28, 2015
Yale Law School's associate professor David Singh Grewal (right), a specialist in IP law and biotechnology and Professor Amy Kapczynski explain how to make drugs-for-all a national priority.


PTI
New Delhi, March 9, 2015
Natco, which markets generic Sofosbuvir under the brand Hepcinat, hopes to launch the drug in India soon, subject to approval from the DCGI.


Sanjeev Jha
November 17, 2014
From a business model innovation perspective, I believe the companies need to leverage both their wealth of experience and market realities.


E. Kumar Sharma
November 4, 2012
India's Intellectual Property Appellate Board has revoked the patent granted in India to F. Hoffmann-La Roche AG (Roche) for pegylated interferon alfa-2a, a medicine used to treat hepatitis C, citing lack of evidence that the drug was better than existing treatments available in the market.


PAGES 1 OF 1